INTERNATIONAL PATENT: VAXCELL-BIO CO., LTD, 주식회사 박셀바이오 FILES APPLICATION FOR "EPCAM AND CD3-BISPECIFIC ANTIBODY FRAGMENT HAVING AFFINITY-MODULATED MUTANT"

GENEVA, Dec. 16 -- VAXCELL-BIO CO., LTD (1F, 12-55, Sandan-gil, Hwasun-eupHWASUN-GUNJeollanam-do 58141), 주식회사 박셀바이오 (전라남도화순구화순읍 산단길 12-55, 1층) filed a patent application (PCT/KR2025/007671) for "EPCAM AND CD3-BISPECIFIC ANTIBODY FRAGMENT HAVING AFFINITY-MODULATED MUTANT" on Jun 04, 2025. With publication no. WO/2025/254457, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inven...